Jacksonville: 904-281-5757 | Memphis: 901-843-1045
Downtown Orlando: 407-425-5100 | Orlando SODO: 407-425-5100
Asthma is a chronic disease of the airways that makes breathing difficult. With asthma, there is inflammation of the air passages that result in a temporary narrowing of the airways that carry oxygen to the lungs.
Managing asthma isn’t always easy. Some asthma treatments cause unwanted side effects, while other asthma treatments don’t always work. Asthma clinical trials, like those at CNS Healthcare, can help you explore new options. Interested in trying a new asthma treatment at no cost? Find out more about enrolling asthma clinical trials available by selecting one of the below locations near you. Use the form on the page to schedule a free, in-office consultation to find out if an asthma trial is right for you.
For some people, asthma is a minor nuisance. For others, it can be a major problem that interferes with daily activities and may lead to a life-threatening asthma attack.
An asthma attack is a sudden worsening of asthma symptoms caused by the tightening of muscles around the airways (bronchospasm). During the asthma attack, the lining of the airways also becomes swollen or inflamed and thicker mucus — more than normal — is produced. All of these factors — bronchospasm, inflammation, and mucus production — cause symptoms of an asthma attack.
Asthma treatment can vary from inhalers to oral medications to drugs delivered in a nebulizer or breathing machine. Asthma medications can save your life and let you live an active life despite your asthma.
Since opening our doors in 1996, CNS Healthcare has had the privilege of assisting in the development of some of the most widely prescribed medicines in the world. We continue to lead the way in providing the clinical research necessary to identify medications for the FDA to review and, once approved, physicians to prescribe. CNS has conducted thousands of clinical trials, improved millions of lives, and is proud to have helped in the FDA approval of nearly 100 new treatments.